Showing results (181-190 of 263) with videos related to
Sort By:
Pageof 27
British Journal of Haematology|February 22, 2011
l-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005-01 randomized trialCarine Domenech, Xavier Thomas, Sylvie Chabaud, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2012
Superior long-term outcome with idarubicin compared with high-dose daunorubicin in patients with acute myeloid leukemia age 50 years and olderClaude Gardin, Sylvie Chevret, Cécile Pautas, et al.Cancer|April 8, 2015
Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL groupThorsten Braun, Sophie Cereja, Sylvie Chevret, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2017
Early Response-Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia StudyJonathan Bond, Carlos Graux, Ludovic Lhermitte, et al.Cancers|May 5, 2021
The Impact of DNMT3A Status on NPM1 MRD Predictive Value and Survival in Elderly AML Patients Treated IntensivelyMaël Heiblig, Nicolas Duployez, Alice Marceau, et al.The Journal of Infection|November 1, 2015
HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patternsAdrien Quintela, Vanessa Escuret, Sandrine Roux, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroupThomas Prébet, Nicolas Boissel, Sarah Reutenauer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2019
Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALLAurore Touzart, Etienne Lengliné, Mehdi Latiri, et al.Investigational New Drugs|April 27, 2011
Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemiaSimona Lapusan, Maria B Vidriales, Xavier Thomas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2004
Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trialXavier Thomas, Jean-Michel Boiron, Françoise Huguet, et al.Pageof 27